Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ImmunoCellular Therapeutics, Ltd

TRADE

AMEX: IMUCHealthcare / Biotechnology / USA
0.037-0.003-7.50%Vol 4 126 7441Y Perf -90.74%
Oct 19th, 2018 15:58
BID0.00 ASK0.00
Open0.04 Previous Close0.04
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potencial %
13 413.50 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)2 
Earnings Rating
Buy
Price Range Ratio 52wk %
1.35 
Earnings Date
20th Nov 2018

Today's Price Range

0.030.04

 

52wk Range

0.030.55

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Month
-82.38%
3 Months
-84.58%
6 Months
-85.77%
1 Year
-90.74%
3 Years
-91.40%
5 Years
-98.73%

Quotes

Name / TickerPriceChg.Chg.%
IMUC0.037-0.0030-7.50
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 8.30
Current Ratio 9.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage 295.20
Leverage Ratio 0.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 0.50
PB Ratio 2.80
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.10
Cash Flow Per Share -0.33
Price to Tangible Book2.80
Book Value per Share0.08
Enterprise Value (in ths.)6 734
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-82.18
ROE last 12 Months -4 268.18
Return on Assets (5Y Avg) -329.33
ROA last 12 Months -206.50
Return on Capital (5Y Avg) -118.15
ROC last 12 Months -3 687.94
Return on invested Capital Q -8.65
Return on invested Capital Y-311.75
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2016-2.00-1.6020.00
Q02 2016-2.80-2.4014.29
Q01 2016-2.80-2.800.00
Q04 2015-1.60-2.40-50.00
Q03 2015-1.60-1.600.00
Q02 2015-0.03-0.030.00
Q01 2015-0.02-0.04-100.00
Q04 2014-0.05-0.0420.00
Earnings Per EndEstimateRevision %Trend
12/2016 QR-1.7626.67Positive
12/2016 FY-6.7011.84Positive
12/2017 FY-8.572.61Positive
----
Next Report Date20th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume4 126 744
Shares Outstanding (in ths.)41 940
Trades Count205
Dollar Volume126 654
Avg. Volume816 002
Avg. Weekly Volume5 310 891
Avg. Monthly Volume1 535 148
Avg. Quarterly Volume600 136

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

29%71%

Bearish Bullish

44%56%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x